Immunotherapy of glioblastoma: Recent advances and future prospects

• Päätekijät: Boyang Yuan (Tekijä), Guoqing Wang (Tekijä), Xin Tang (Tekijä), Aiping Tong (Tekijä), Liangxue Zhou (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Glioblastoma (GBM) stands out as the most common, aggressive form of primary malignant brain tumor conferring a devastatingly poor prognosis. Despite aggressive standard-of-care in surgical resection and chemoradiation with temozolomide, the median overall survival of patients still remains no longe...